Скачать с ютуб Important Export Control Considerations For The Life Sciences Industry в хорошем качестве

Important Export Control Considerations For The Life Sciences Industry

Join us to learn about the nuts and bolts of export controls - including potential regulatory restrictions - confronting manufacturers and distributors of medical devices, pharmaceuticals, and other technologies who sell their products to foreign buyers. One of the main takeaways of this webinar should be that just because your product(s) may be classified or controlled for export does not mean that your desired foreign sales should be significantly disrupted. 00:00 - Intro About the Speaker; Andrew Astuno | Fluet 04:48 - Overview of Export Compliance 06:08 - Exports under the International Traffic in Arms Regulations (“ITAR”) and Export Administration Regulations (“EAR”) 11:22 - What Constitutes “Technology” Under the EAR? 13:22 - Exporting from the U.S. 13:25 - How to obtain an Export Control Classification Number (ECCN) 24:12 - Foreign Government Requirements: Exporting Medical Devices to the EU 30:51 - The Foreign Corrupt Practices Act (FCPA) 34:09 - Sanctions Compliance 42:39 - Questions and Closing Presented by Andrew Astuno, Esq. Andrew Astuno is an attorney focused on US export controls, international economic regulations, and anti-corruption. Andrew, a former Policy Advisor at the US Treasury, specializes in conducting reviews for proposed foreign acquisitions in the United States before the Committee on Foreign Investment in the United States (CFIUS). He also advises US and international clients in matters involving compliance with the Export Administration Regulations (EAR), International Traffic in Arms Regulations (ITAR), the Office of Foreign Assets Control (OFAC), and the Foreign Corrupt Practices Act (FCPA). Andrew develops compliance procedures, conducts due diligence on transactions, performs internal investigations, and counsels clients through government enforcement actions.